Genmab — Maj 2025
-
Maj Status: NVIDIA, toldsatser, Novo, Zealand Pharma, Gubra, Genmab, Embla Kort video: https://proinvestor.com/boards/126575
-
Godmorgen

-
Summets PD1 x EGFR bispecifik fejlede endpoint OS i fase 3 https://finance.yahoo.com/news/ivonescimab-plus-chemotherapy-demonstrates-statistically-100000274.html
-
Et åbent spørgsmål.. Hvor meget fylder Genmab af jeres portefølje?.. Jeg sidder og tænker over, om man bør hælde mere i Genmab til disse kurser - måske forsøge og fange hvis den tager et dyk til ned omkring 1200.. Pt. fylder Genmab godt 3-4% hvilket er meget normalt hos mig for enkeltaktier..
-
Lymphoma Hub
@lymphomahub
CONGRESS | #ASCO25 | PRESENTATION
@DrJulieVoseshares insights on incorporating epcoritamab into clinical practice for the treatment of patients with R/R FL.
They highlight results from the pivotal FL cohort of the EPCORE NHL-1 trial (N = 128) and discuss key considerations for monitoring in the outpatient setting. https://x.com/lymphomahub/status/1928522519759270376 https://x.com/VJHemOnc/status/1928525984988360814
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind